Johnson & Johnson buy MoneyMoney
Summary
This prediction ended on 28.11.22 with a price of €170.74. The BUY prediction by MoneyMoney finished with a performance of 21.35%. A total of €4.23 was paid as dividends for this prediction. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Johnson & Johnson | 2.244% | 2.244% | 2.662% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% |
According to MoneyMoney what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
Cons
Comments by MoneyMoney for this prediction
In the thread Johnson & Johnson diskutieren
In the thread Trading Johnson & Johnson